GSK plc
GSK
#228
Rank
NZ$175.00 B
Marketcap
NZ$87.31
Share price
-0.13%
Change (1 day)
3.45%
Change (1 year)

EPS for GSK plc (GSK)

EPS in 2026 (TTM): NZ$5.04

According to GSK plc's latest financial reports the company's current EPS (TTM) is NZ$5.26. In 2025 the company made an earnings per share (EPS) of NZ$6.89 an increase over its 2024 EPS that were of NZ$2.91.

EPS history for GSK plc from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$5.04-26.83%
2025NZ$6.89136.36%
2024NZ$2.91-47.35%
2023NZ$5.54-64.2%
2022NZ$15.46182.29%
2021NZ$5.48-18.07%
2020NZ$6.6922.34%
2019NZ$5.4623.9%
2018NZ$4.41140.61%
2017NZ$1.8364.45%
2016NZ$1.11-90.61%
2015NZ$11.87178.12%
2014NZ$4.27-48.11%
2013NZ$8.2222.68%
2012NZ$6.70-11.31%
2011NZ$7.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
NZ$9.60 82.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.30-75.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.62-31.17%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$1.82-65.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$13.02 147.45%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$0.82-84.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
NZ-$0.58-111.12%๐Ÿ‡บ๐Ÿ‡ธ USA